Rising prevalence of obesity, growing geriatric population with higher risk of heart diseases, and rapid technological advancements to detect arrhythmia are critical factors for the growth of the transseptal access systems market.
Introduction of innovative technologies such as left atrial appendage occlusion therapy is benefitting patients who are at high risk of strokes due to non-valvular atrial fibrillation (AF). These developments not only prolong survival rate, but also reduce morbidity and enhance quality of life.
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/18703
Gain More Insights about this Report
Key Takeaways of Transseptal Access Systems Market Study
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/18703
The global transseptal access systems market was valued at US$ 638 Mn in 2018 and is expected to witness a CAGR of 9.8% during the forecast period (2019–2029).
“Launch of new product lines and continuous improvements in available systems have enhanced the safety and efficacy of transseptal access systems. Substantial increase in interest for transseptal heart catheterization is leading to the growth of transseptal access systems market” says a PMR Analyst.
New Product Launches – Winning Strategy of Leading Transseptal Access System Manufacturers
Continuous up-gradation and innovation in transseptal access systems are responsible for intense competition among players in the transseptal access systems market. Numerous organizations are focusing on new product approvals for transseptal access systems.
For example, in Jan 2019, Baylis Medical launched ExpanSure, a transseptal access system that combines a dilator and sheath into a single device, which assists in larger dilation as compared to fixed curve sheaths. In 2018, Transseptal Solutions Ltd received FDA approval for the TSP Crosser Transseptal Access System, which is designed to provide stable catheter positioning and controlled access. These winning strategies by leading players are also being followed by regional and local players.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/18703
More Valuable Insights on Transseptal Access Systems Market
Persistence Market Research offers a unique perspective and actionable insights on transseptal access systems in its latest study, presenting historical demand assessment from 2014–2018 and projections from 2019–2029, on the basis of product type (transseptal access sheaths and transseptal access needles), application (AF ablation, MV repair, and LAA occlusion), and end user (hospitals, ambulatory surgical centers, and specialty clinics), across five major regions.
Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape
Next-Generation Sequencing Market –
Next Generation Sequencing Market Segmented by(By Application – Whole-genome Sequencing ,Exome Sequencing,Targeted Resequencing,De Novo Sequencing,RNA Sequencing,ChIP Sequencing,Methyl Sequencing,Others);By Technology- Targeted Sequencing & Resequencing,Whole Genome Sequencing,Whole Exome Sequencing.
Ophthalmology devises Market –
Ophthalmology devises Market Segmentation by Key Players – Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.
Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
U.S. Phone - +1-646-568-7751
U.S.-Canada Toll-free : +1 800-961-0353
E-mail id - sales@persistencemarketresearch.com
Website : www.persistencemarketresearch.com